Question 1

What is Novaqis?

Accepted Answer

Novaqis (Novaqis Technologies LLP, Vadodara) develops a modular suite for regulated operations. Admin covers identity, organizations, licensing, SSO, and server monitoring; DMS delivers GxP document management—workflows, change control, controlled print, training gates, and audit trails; LMS and QMS provide training competency and quality events on the same platform; BRM delivers electronic batch and production records with DMS and LMS interlocks; AuditLens provides cross-system audit and inspection intelligence; Reporting provides session and lifecycle insight without shadow exports; and Nova AI is our pharma-ready, on-premises assistant—with a dedicated knowledge module administrators control—for document work, operational summaries, AuditLens compliance queries, and reporting-oriented queries within your perimeter. Founded by Ashutosh Biswal in 2025.

Novaqis addresses unstable legacy implementations, dated UX, and high TCO with a production-grade alternative teams can validate and operate with confidence.

Question 2

Is Novaqis a good DMS for pharmaceutical companies?

Accepted Answer

Novaqis DMS is built for pharmaceutical and biotech quality use cases: controlled documents, workflows, signatures, change control, controlled print, and auditability, with design themes aligned to 21 CFR Part 11 and EU Annex 11. Suitability depends on your validation strategy—we recommend guided evaluation and IQ/OQ/PQ in your environment.

Question 3

Does Novaqis support 21 CFR Part 11-style electronic records?

Accepted Answer

Novaqis DMS is engineered with Part 11–relevant capabilities (electronic records, signatures, traceability). Compliance is a shared responsibility: your organization validates the system in context. We do not claim automatic regulatory approval.

Question 4

We are evaluating several validated DMS vendors—how should we look at Novaqis?

Accepted Answer

Treat Novaqis as a peer competitor on the same shortlist. Compare deployment, functional fit for SOPs and Part 11 scope, workflows, controlled print, change control, integration with identity and reporting, and TCO. We welcome deep technical due diligence.

Question 5

Can we deploy on our own infrastructure?

Accepted Answer

Yes. Novaqis runs inside your perimeter—on-premises or in your cloud—so data residency stays under your governance. This is a common requirement for Indian pharmaceutical plants and other regulated manufacturers with residency or sovereignty policies.

Question 6

Is Novaqis suitable for pharmaceutical companies in India?

Accepted Answer

Yes. We are based in Vadodara and build for plants that serve India and export markets—run on your infrastructure, work in languages your teams use, and grow users and sites without a surprise seat bill. Your quality system and validated state decide compliance; we help you operate documents, training, quality, batch records, and inspection readiness on one platform. See Solutions → India pharma.

Question 7

What is Novaqis BRM?

Accepted Answer

Novaqis BRM helps manufacturing teams move from paper packs to electronic batch records—recipes, execution, clearance, and floor logbooks—connected to the documents and training your plant already governs, and to quality holds when those modules are part of your suite.

Question 8

What is Novaqis AuditLens?

Accepted Answer

Novaqis AuditLens helps teams plan audits, rehearse before the visit, and see how documents, training, quality, and batches connect across the Novaqis modules you license—so inspection prep is calmer than overnight spreadsheets.

Question 9

Do you charge per user or per site (plant)?

Accepted Answer

No. Novaqis does not charge extra for user licenses or plant (site) licenses. Users and sites are included without a seat or plant cap in our standard model—so growth in headcount or manufacturing footprint does not automatically multiply license cost the way many enterprise suites do. Confirm scope for your deployment during presales.

Question 10

How does Novaqis compare on platform license cost and AMC?

Accepted Answer

Novaqis platform license and annual maintenance (AMC) are positioned at roughly half of comparable enterprise pharma DMS and quality suite quotes—among the strongest commercial models in the category. A complete documents + training + quality suite often costs less than many plants pay for document control alone. Exact figures depend on modules, instance count (Production vs Training), and services. Many teams also reduce Microsoft Word seat spend because controlled authoring runs in our built-in editor. We do not publish list prices—contact us for a tailored quote. See Value & TCO.

Question 11

Is Novaqis validated out of the box?

Accepted Answer

Software is GxP-oriented; your organization performs IQ/OQ/PQ in your environment. We discuss documentation and deployment models during presales.

Question 12

What do Novaqis LMS and QMS cover?

Accepted Answer

Novaqis LMS covers curricula, governed PDF/HTML reading with camera-assisted attention and identity monitoring, virtual training rooms for ILT/OJT, AI comprehension checkpoints, assessments with lock-on-fail, document-linked retraining, and competency evidence on the same identity and audit fabric as Admin and DMS. Novaqis QMS covers Configuration Studio for governed forms and workflows, AI-assisted workflow design and question generation, plus deviation, CAPA, change control, audit, complaint, OOS/OOT, and management review—with suite-native traceability to DMS and LMS.

Frequently asked questions

General

Nova AI

Products

Deployment

Licensing